A previous study [34] proposed a CRC-related survival prediction model for preoperative CEA-normal patients, but the number of samples was limited and the predictive significance of serum tumor markers for patients was not fully evaluated, which greatly limited the application of the model in preoperative CEA-normal patients. This evidence concerns the gene CEACAM5 and neoplasm.